What ARRAY BIOPHARMA INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cox Carrie Smith | Director | Jul 30 | Disposition to Issuer · D | −10,000 | — | — | 0 |
| Cox Carrie Smith | Director | Jul 30 | Disposition to Issuer · D | −8,000 | $48.00 | −$384K | 10,000 |
| Baum Charles M | Director | Jul 30 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Baum Charles M | Director | Jul 30 | Tender Offer · U | −15,000 | $48.00 | −$720K | 5,000 |
| Orwin John A | Director | Jul 30 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Orwin John A | Director | Jul 30 | Disposition to Issuer · D | −15,000 | $48.00 | −$720K | 5,000 |
| Robbins Andrews R | COO | Jul 30 | Disposition to Issuer · D | −130,542 | — | — | 0 |
| Robbins Andrews R | COO | Jul 30 | Disposition to Issuer · D | −71,022 | $48.00 | −$3.41M | 130,542 |
| Sandor Victor | Chief Medical Officer | Jul 30 | Disposition to Issuer · D | −114,821 | — | — | 0 |
| Sandor Victor | Chief Medical Officer | Jul 30 | Disposition to Issuer · D | −209,543 | $48.00 | −$10.1M | 114,821 |
| Saccomano Nicholas A | CSO | Jul 30 | Disposition to Issuer · D | −61,813 | — | — | 0 |
| Saccomano Nicholas A | CSO | Jul 30 | Disposition to Issuer · D | −150,190 | $48.00 | −$7.21M | 61,813 |
| Sharp Shalini | Director | Jul 30 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Sharp Shalini | Director | Jul 30 | Disposition to Issuer · D | −5,000 | $48.00 | −$240K | 5,000 |
| Squarer Ron | CEO | Jul 30 | Disposition to Issuer · D | −442,190 | — | — | 0 |
| Squarer Ron | CEO | Jul 30 | Disposition to Issuer · D | −259,891 | $48.00 | −$12.5M | 442,190 |
| Haddock Jason | CFO | Jul 30 | Disposition to Issuer · D | −30,059 | $48.00 | −$1.44M | 56,026 |
| Fyfe Gwen A. | Director | Jul 30 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Fyfe Gwen A. | Director | Jul 30 | Disposition to Issuer · D | −15,000 | $48.00 | −$720K | 5,000 |
| Lefkoff Kyle | Director | Jul 30 | Disposition to Issuer · D | −30,000 | $48.00 | −$1.44M | 0 |
Loading...
